Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy
Clinical trial NCT05204160 · WITHDRAWN
Trial details
- NCT number
- NCT05204160
- Sponsor
- Emory University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2024-02-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.